Newswire
ภาษาไทย
English-
CISION PR Newswire - BLUETTI Unveils Cutting-Edge Solar Solutions for O...
LAS VEGAS, April 30, 2024 /PRNewswire/ -- Ensuring ample power on overlanding adventures is crucial for keeping your fridge running and communication equipment charged. There are two key ways to do th... -
CISION PR Newswire - Tungray Technologies Inc Announces Partial Exercis...
SINGAPORE, April 30, 2024 /PRNewswire/ -- Tungray Technologies Inc (the "Company" or "Tungray") (NasdaqCM: TRSG), a provider of customized industrial manufacturing solutions to Original Equipment Manu... -
CISION PR Newswire - GCL SI's Net Profit Soars by 142.24% in 2023, Rank...
SUZHOU, China, April 30, 2024 /PRNewswire/ -- GCL System Integration Technology Co Ltd (GCL SI) (Shenzhen:002506) disclosed its financial results for the fiscal year ended December 31, 2023, in a pres... -
CISION PR Newswire - Facemoji Honored as Gold Stevie® Award Winner in 2...
Facemoji Keyboard app recognized for best use of generative AI technology SUNNYVALE, Calif., April 30, 2024 /PRNewswire/ -- Facemoji Keyboard, the world's first content-creation keyboard with rich in-... -
CISION PR Newswire - Eluminex Biosciences Announces FDA Acceptance of I...
SAN FRANCISCO and SUZHOU, China, April 30, 2024 /PRNewswire/ -- Eluminex Biosciences (Eluminex), a privately-held biotechnology company focused on the development of advanced protein therapeutics for ... -
CISION PR Newswire - Ransomware and extortion incidents surged by 67% i...
Bad actors are using more aggressive and unscrupulous tactics to acquire personal data and extort ransoms TOKYO, April 30, 2024 /PRNewswire/ -- Ransomware and extortion incidents surged by 67% in 2023... -
CISION PR Newswire - Zepp Health Announces US Launch Date for Amazfit H...
-Redefining Athletic Recovery & Performance Monitoring, with Global Rollout Ahead MILPITAS, Calif., April 30, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health") (NYSE: ZEPP), a global le... -
CISION PR Newswire - Jacobio Pharma Announced its KRAS G12C inhibitor r...
BEIJING and SHANGHAI and BOSTON, April 30, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced that the data from the Phase II registrational study of the KRAS G12C inhibitor glecirasib were offic... -
CISION PR Newswire - Integrated cancer biotech Infinitopes secures £12....
Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1 OXFORD, England, May 1, 2024 /PRNewswire/ -- Infinitopes Precision Immunomics, an integrated cancer biotech combining world... -
CISION PR Newswire - APPRO Extends Partnership With Silent Eight To Enh...
SINGAPORE, May 1, 2024 /PRNewswire/ -- APPRO, a digital powerhouse that simplifies the onboarding journey in retail banking, proudly announces the successful expansion of its strategic partnership wit...
The information provided in this article was created by CISION PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of ELITE Beauty.